Session Pulse

Headlines

Prediction: This Dividend ETF Will Thrive After 20 Years No Matter What the Market Does The Motley Fool · Jul 28, 6:30 AM ET After Soaring Nearly 90% Thus Far in 2026, Is Moderna's Stock Still a Buy? The Motley Fool · Jul 27, 4:02 PM ET Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026 GlobeNewswire Inc. · Jul 26, 7:30 PM ET 2 Top Growth Stocks to Buy Right Now Without Any Hesitation The Motley Fool · Jul 24, 12:30 AM ET

1 of 1 sentiment tags ran bullish across 1 mentions

$SLS my read on where a buyout of $SLS by big pharma stands My own belief is that multiple big pharma companies are already reviewing $SLS... 10xorbust · Jul 20, 9:16 AM ET · bullish tag @Blockchainsaw I will be cashing quarterly $LLY / $ABBV or $MRK Dividend Checks... 55X_ROI_Q1_2026 · Jul 20, 12:22 AM ET @lifeofparty I get the feeling that Sterg won’t be the one discussing affordability before product launch. Better left to $MRK or $JNJ. BioPhoenix · Jul 19, 11:13 AM ET · bullish tag $GLSI why would anyone be invested here now supporting snehel and his family with the p3 trial results 18 months away while $SLS has more... HboFam · Jul 18, 11:23 PM ET @Duncan74 no big pharma company is paying $10 billion plus (or $20 billion or $30 or $40) for $SLS without the Regal results being a big... 10xorbust · Jul 18, 9:54 AM ET · bullish tag $MRK https://stratafinance.beehiiv.com/p/merck-co Ndellomo · Jul 18, 8:35 AM ET $MRK will definitely move higher towards 200, with 12-15 months. new pill manufactured by Merck, called Lipfendra, is taken once a day as an... scotttrader213 · Jul 18, 7:04 AM ET